Document:

Consulting Agreement

 EXHIBIT 10.23 
  
 CONSULTING AGREEMENT 
  

Salmedix, Inc. 
 8521 D Villa La Jolla Drive 
 La Jolla, CA 92037 
  
 To whom it may concern: 
  
 The
following contains all the items of my Consulting Agreement (the “Agreement”), effective as of December 1, 2000 (the “Effective Date”), with Salmedix, Inc. (the “Company”). 
  
 The amount of time I will spend as a consultant to the Company (a
“Consultant”) and the nature of the services provided and my compensation are set forth in Exhibit A hereto. In rendering such services to the Company, I shall act as an independent contractor and not as an employee of the Company.
This Agreement shall commence on the Effective Date and shall have an initial term of one (1) year. This Agreement shall thereafter renew automatically for subsequent one (1) year terms, unless either party gives notice of its intent to terminate no
less than sixty (60) days prior to the end of the then-current term. Subject to the foregoing, either party may terminate this Agreement with or without cause. 
  

I understand that the Company possesses and will possess Proprietary Information which is important to its business. For purposes of this Agreement,
“Proprietary Information” is information that was or will be developed, created, or discovered by or on behalf of the Company, or which became or will become known by, or was or is conveyed to the Company, which has commercial value in the
Company’s business (including, without limitation, information created, discovered, developed or made known by or to me arising specifically out of my retention as a Consultant by the Company). By way of illustration, but not limitation,
“Proprietary Information” includes information (whether conveyed orally or in writing) about biological materials, nucleic acids, proteins, cell lines, antibodies and antigen source materials or fragments thereof, chemical compounds, trade
secrets, designs, technology, ideas, know-how, products, services, processes, data, techniques, improvements, inventions (whether patentable or not), works of authorship, business and product development plans, marketing plans, strategies,
forecasts, the salaries and terms of compensation of employees of or other consultants to the Company, customer lists and other information concerning the Company’s actual or anticipated business, research or development, or which is received
in confidence by or for the Company from any other person. 
  
 In
consideration of my retention as a Consultant and the compensation received by me from the Company from time to time, I hereby agree as follows: 
  
 1. All Proprietary Information shall be the sole property of the Company and its assigns, and the Company and its assigns shall be the sole owner of all
patents and other rights in connection therewith. I hereby assign to the Company any rights I may have or acquire in all Proprietary Information. At all times during my retention as a Consultant by the Company and at all times after termination of
such retention as a Consultant, I will keep in confidence and trust all Proprietary Information, and I will not disclose, sell, use, lecture upon or publish any Proprietary Information without the written consent of the Company, except as may be
necessary in the ordinary course of performing my duties as a Consultant of the Company. 
  
 2. I agree that during the period that I am retained as a Consultant to the Company I will not, without the Company’s express written consent, except as permitted by this Section 2, engage in 

 any employment or activity (whether as a consultant, advisor or otherwise) in any business within the field of drugs for
lymphoproliferative diseases and cancer (the “Field”) or such other businesses as the Company may from time to time subsequently engage. The Company recognizes that I currently have certain agreements and perform consulting services for
others. During the thirty (30) days following the execution of this Agreement, the Company and I will review such agreements and services to determine whether they constitute activities which would be in conflict with the Agreement. If the
Company’s Board of Directors determines that any such activity conflicts with this Agreement, the Company shall have the right to immediately terminate this Agreement with no obligation to me. In addition, prior to entering into any additional
agreement, I shall submit such additional agreement to the Company which will, within thirty (30) days of such submission, advise me whether the Company has concluded that entering into such additional agreement would conflict with this Agreement.
If the Company has so concluded I will notify the Company within ten (10) days that I will not enter into the additional agreement or that I will terminate this Agreement. 
  
 3. All documents, data, records, hardware, software and other physical property, whether or not pertaining to Proprietary
Information, furnished to me by the Company or produced by myself or others in connection with my retention as a Consultant shall be and remain the sole property of the Company and shall be returned promptly to the Company as and when requested by
the Company. Should the Company not so request, I shall return and deliver all such property upon termination of my retention as a Consultant by me or by the Company for any reason and I will not take with me any such property or any reproduction of
such property upon such termination. 
  
 4. I agree that for a
period of one (1) year following termination of my retention as a Consultant with the Company, I will not solicit or in any manner encourage employees of the Company to leave its employ. 
  
 5. I will promptly disclose to the Company, or any person designated by it, all improvements, inventions, formulae,
processes, techniques, know-how and data, whether or not patentable, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my retention as a Consultant which (a) arise from services
provided by me under this Agreement and are related to or useful in the business of the Company, or (b) result from tasks assigned to me by the Company, or (c) are funded by the Company, or (d) result from use of premises owned, leased or contracted
for by the Company (all said improvements, inventions, formulae, processes, techniques, know-how and data shall be collectively hereinafter called “Inventions”). Such disclosure shall continue for one (1) year after termination of this
Agreement with respect to anything that would be an Invention if made, conceived, reduced to practice or learned during the term hereof. 
  
 6. I agree that all Inventions shall be the sole property of the Company and its assigns, and the Company and its assigns shall be the sole owner of all
patents and other rights in connection therewith to the maximum extent that would be permitted by Section 2870 of the California Labor Code, a copy of which is attached as Exhibit A, if I were an employee of the Company. This assignment shall not
extend to Inventions, the assignment of which is prohibited by Labor Code Section 2870. I hereby assign to the Company any rights I have or acquire in all Inventions. I further agree as to all Inventions to assist the Company at any time, and not
just during the term of this Agreement, in any and all countries, which assistance shall include the execution of documents and any assignments to the Company or persons designated by it. In the event that the Company is unable for any reason
whatsoever to secure my signature to any lawful and necessary document required to apply for or execute any patent application with respect to an Invention(s) (including reissues, renewals, extensions, continuations, divisions or continuations in
part thereof), I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents, as my agents and attorneys-in-fact to act for and in my behalf and 

 instead of me, to execute and file any such application and to do all other lawful acts to further the prosecution and
issuance of patents thereon with the same legal force and effect as if executed by me. 
  
 7. As a matter of record I have attached hereto as Exhibit B a complete list of all inventions or improvements related to the subject matter of my retention as a Consultant by the Company which have been made
or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company which I desire to remove from the operation of this Agreement; and I covenant that such list is complete. 
  
 8. I understand as part of the consideration for the offer of retention as a
Consultant or continued retention as a Consultant by the Company, that I have not brought and will not bring with me to the Company or use in the performance of my responsibilities at the Company any equipment, supplies, facility or trade secret
information of any current or former employer which are not generally available to the public, unless I have obtained written authorization for their possession and use. 
  
 9. I also understand that, in my retention as a Consultant with the Company, I am not to breach any obligation of
confidentiality that I have to others, and I agree that I shall fulfill all such obligations during my retention as a Consultant with the Company. 
  
 10. I agree that in addition to any other rights and remedies available to the Company for any breach by me of obligations hereunder, the Company shall be
entitled to enforcement of my obligations hereunder by court injunction. 
  
 11. If any provision of this Agreement shall be declared invalid, illegal or unenforceable, such provision shall be severed and all remaining provisions shall continue in full force and effect. 
  
 12. I agree that any dispute in the meaning, effect or validity of this
Agreement shall be resolved in accordance with the laws of the State of California without regard to the conflict of laws provisions thereof by a court of competent jurisdiction located in San Diego, California. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements, in addition to any other relief to which the party may be entitled.

  
 13. I agree that this Agreement may be terminated by either
the Company or by me at any time, for any reason, with or without cause, by giving written notice to the other party; termination to be effective upon the other party’s receipt of notice. 
  
 14. This Agreement shall be binding upon me, my heirs, executors, assigns and
administrators and shall inure to the benefit of the company, its successors and assigns. 
  
 Dated: December 1, 2000 
  
 /s/ David S. Kabakoff         
 David S.
Kabakoff 
  
 Address: P.O. Box 9151 

Rancho Santa Fe, CA 92067 
  
 ACCEPTED AND AGREED TO: 
  
 SALMEDIX, INC. 
  

			
	 
		
	By:	 	/s/ Anita I. Busquets
	 	 	

	 	 	 Anita I. Busquets
 Vice President – Finance and Administration

  
 [SIGNATURE PAGE TO
CONSULTING AGREEMENT] 

 EXHIBIT A 
  

			
	 Amount:
	  	Consultant shall render such services at such times and places as the Company may request.
		
	 Nature of Consulting:
	  	Consultant shall consult with and provide services to the Company on an exclusive basis within the Field.
		
	 Compensation:
	  	$12,500.00 per month

  

 EXHIBIT B 
  
 Salmedix, Inc. 
 8521 D Villa La Jolla Drive

 La Jolla, CA 92037 
  
 To whom it may concern: 
  
 The following is a complete list of all inventions or improvements or works of authorship relevant to the subject matter of my consulting for Salmedix,
Inc. (the “Company”) that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my consulting for the Company. I desire to remove those inventions and improvements listed, if any, from the
operation of the Consulting Agreement between the Company and me which are noted by an “*” and my initials next to such invention or improvement: 
  
     X     No inventions or improvements. 
  
            See below. 
  
            Additional sheets attached. 
  
 /s/ David S.
Kabakoff         
 David S. Kabakoff 
  
 December 1, 2000 

 EXHIBIT C 
  
 Section 2870. Invention on Own Time — Exemption from Agreement 
  

	(a)	Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not
apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: 

  

	 	(1)	Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the
employer. 

	 	(2)	Result from any work performed by the employee for his employer. 

  

	(b)	To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision
(a), the provision is against the public policy of this state and is unenforceable.1st Amendment to the Licence Agreement

 EXHIBIT 10.24 
  
 1st AMENDMENT 

  
 to the LICENCE AGREEMENT of May 1, 2003 
  
 by and
between FUJISAWA Deutschland GmbH, a corporation organized and existing pursuant to the laws of Germany and having its registered office at Berg-am-Laim-Strasse 129, 81673 München, Germany (hereinafter referred to as “F-DE”) and
SALMEDIX, Inc., a corporation organized and existing pursuant to the laws of Delaware, having its principal office at 9380 Judicial Drive, San Diego, CA 92121, United States of America (hereinafter referred to as “SALMEDIX”). 

 
 F-DE and SALMEDIX mutually agree to amend the LICENCE AGREEMENT of May 1, 2003 between the
parties hereto as follows: 
  
 1. AMENDMENT OF ARTICLE 2 

 
 Paragraph 1 of Article 2 shall be replaced as follows: 
  
 1) F-DE grants to SALMEDIX an exclusive right and license under its Scientific Information
and Data (hereinafter defined) to develop, market, sell, import, distribute and promote the Product for all clinical indications under a SALMEDIX trademark in the Territory and to manufacture and have manufactured the Product, the Compound and any
and all drug intermediates of the same (whether within or without the Territory, but solely for the marketing, sale, distribution and promotion within the Territory). 
  
 2. OTHER 
  
 Except as specifically provided in this Amendment, the LICENCE AGREEMENT of May 1, 2003 shall remain unchanged an continue in full force and effect as it is. 

 

									
	 Munich, July 21, 2003
  
 FUJISAWA DEUTSCHLAND GmbH
	 	 	 	 San Diego,
  
 SALMEDIX, INCORPORATED

			
	 /s/ W. Tinhof

	 	 	 	 /s/ David S. Kabakoff

	 Dr. W. Tinhof, President
	 	 	 	 David S. Kabakoff, Chairman and CEO

				
	 /s/ W. Schoch

	 	 	 	 	 	 
	 W. Schoch, Executive Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]